Eva Karlsson

Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression

Linda S. Lindström, Eva Karlsson, Ulla Wilking et al. · Journal of Clinical Oncology · 2012 · 517 citations

Hormonal Receptors, Breast Oncology, Progesterone Receptor +15

The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm

Lars L. Gustafsson, Björn Wettermark, Brian Godman et al. · Basic & Clinical Pharmacology & Toxicology · 2011 · 220 citations

HER2 status in a population-derived breast cancer cohort: discordances during tumor progression

Ulla Wilking, Eva Karlsson, Lambert Skoog et al. · Breast Cancer Research and Treatment · 2010 · 118 citations · Full text

Her2 Status, Breast Oncology, Cancer Epidemiology +7

Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer

Theodoros Foukakis, Gϋnter von Minckwitz, Nils‐Olof Bengtsson et al. · JAMA · 2016 · 97 citations

Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations

Linda Björkhem‐Bergman, Eva Karlsson, Richard Laing et al. · European Journal of Clinical Pharmacology · 2013 · 85 citations

Primary Care, Medicine, Interface Management +10